Monthly Newsletter

As many products come off patent, this is causing ‘game-changing' falls in revenues. Consequently, industry is grappling with questions pertaining to the most effective strategies for developing meaningful new drugs and how it should collectively fund and reward their discovery and development activities.

Gone are the days that pharma companies can 'go it alone'. As a result, companies in the life sciences sector must think creatively in order to gain maximum potential and benefits from their partnering and collaboration strategies and models.

Following on from a portfolio of successful pharmaceutical events, SMi are proud to present their European BioNetworks Summit, taking place on the 7th and 8th July, 2014 in Central London. This important and timely meeting will allow biotech, pharma, academic and funding organisations to evaluate how they partner with other stakeholders in the field to accelerate research and reduce costs.

Join us and hear timely case studies, presentations, roundtables and panel discussions on the hottest topics, from leading experts as they demonstrate how to create winning strategic partnerships from modern day collaborations!

For further information click here